The Alexandra General Hospital is a General hospital in central Athens, Greece. It was established in 1954, initially as a Maternity Hospital and later as a Maternity & Obstetrics - Gynecological Hospital. It is located at Vassilisis Sofias avenue in the center of Athens.

There are 350 beds in General Hospital Alexandra.

During the past decade, General Hospital Alexandra conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Alexandra" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital Alexandra" are "Atrial Fibrillation" (1 trials), "Lactation" (1 trials), "Non-small Cell Lung Cancer Metastatic" (1 trials), "Pregnancy" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "General Hospital Alexandra" in a lesser frequency.

Most popular intervention types in "General Hospital Alexandra" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Vx-001" (1 trials), "bosentan" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Alexandra" are 4 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital Alexandra". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in General Hospital Alexandra, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Alexandra, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".